Trials / Terminated
TerminatedNCT02729207
Proof-of-concept Study of NSAID Hydrogel Patch in Treatment of Acute Pain
A Phase II, Randomized, Double-blind, Placebo Controlled, Proof of Concept Study to Investigate the Safety and Efficacy of the Esflurbiprofen Hydrogel Patch in Treatment of Acute Pain Associated With Ankle Injury
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Teikoku Seiyaku Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The safety and the efficacy of the Esflurbiprofen Hydrogel Patch will be assessed in comparing with placebo in the treatment of acute pain due to ankle sprain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esflurbiprofen Hydrogel Patch | One patch per day for 7 days |
Timeline
- Start date
- 2016-07-01
- Primary completion
- 2016-12-21
- Completion
- 2016-12-27
- First posted
- 2016-04-06
- Last updated
- 2021-10-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02729207. Inclusion in this directory is not an endorsement.